A comprehensive view of Oral Medicines / Supplements. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Roche's Evrysdi shows 91% of treated children with SMA achieved or maintained sitting, standing or walking abilities after 5 years; 96% could swallow, 80% could feed without a feeding tube.

EU's CHMP recommends approval of AstraZeneca's Tagrisso with chemotherapy to treat EGFR-mutated lung cancer; FLAURA2 trial results show 38% reduced risk of disease progression or death

Johnson & Johnson submits supplemental new drug application to FDA seeking expanded pediatric indication for HIV-1 therapy PREZCOBIX; application aims to treat HIV-1 infection in children at least 6 years old and weighing at least 25 kg.

AbbVie's RINVOQ now available for pediatric patients two years and older with polyarticular juvenile idiopathic arthritis and psoriatic arthritis; FDA approved for eight indications across immune-mediated inflammatory diseases.

Novartis launches Entresto Granular Tablets in Japan for pediatric patients with chronic heart failure; the product contains sacubitril valsartan sodium hydrate

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count